Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Illinois Ventures
AddedFeb 15, 2024
UpdatedJun 28, 2026
Illinois Ventures

Illinois Ventures

Operating

Chicago-based Illinois Ventures: A seed-stage investment firm specializing in tech and financial services.

Location
Chicago, IL, US
Founded
2000
Firm
Compare
Portfolio
Employees
Website

Investments

Cadenza Bio
Cadenza Bio

Total Raised

$2.4M

Rounds

1

Seed$2.4MDecember 2023
Integrated Dynamics
Integrated Dynamics

Total Raised

$120k

Rounds

1

Angel$120kAugust 2023
Natrion
Natrion

Total Raised

$3M

Rounds

6

Seed$1.8MMay 2022
Ascent Integrated Tech
Ascent Integrated Tech

Total Raised

$6.3M

Rounds

4

Seed$1.2MJanuary 2022
Mesh++
Mesh++

Total Raised

$10M

Rounds

11

Series Unknown$4.9MOctober 2021
Seed$4.9MOctober 2019
Pre-SeedSeptember 2017
Ocient
Ocient
Series B

Total Raised

$107.2M

Rounds

6

Series B$40MJanuary 2021
cystetic Medicines
cystetic Medicines

Total Raised

$25M

Rounds

1

Undisclosed$25MDecember 2020
Network Perception
Network Perception

Total Raised

$16.6M

Rounds

4

Seed$2.7MDecember 2020
Amber Agriculture
Amber Agriculture

Total Raised

$3.3M

Rounds

3

Seed$2.1MJune 2020
Apervita
Apervita

Total Raised

$59.5M

Rounds

5

Series Unknown$22MNovember 2019
Lightform
Lightform

Total Raised

$16.9M

Rounds

5

Series A$8.7MJune 2019
Vitrix Health
Vitrix Health

Total Raised

$115k

Rounds

2

Pre-Seed$115kMarch 2019
Xaptum
Xaptum
Acquired

Total Raised

$5.6M

Rounds

3

Seed$3.1MOctober 2018
Reconstruct
Reconstruct

Total Raised

$27.6M

Rounds

5

Seed$850kSeptember 2016
Aptimmune Biologics
Aptimmune Biologics
Debt

Total Raised

$8.8M

Rounds

5

Series A$2.8MMarch 2016
Diagnostic Photonics
Diagnostic Photonics

Total Raised

$3M

Rounds

4

Series B$3MJanuary 2016
PhotoniCare
PhotoniCare

Total Raised

$18.2M

Rounds

15

Seed$250kJune 2015
Chromatin
Chromatin

Total Raised

$122.3M

Rounds

10

Series F$12MJanuary 2015
Series E$36MJanuary 2014
Revenew
Revenew

Total Raised

$10.5M

Rounds

3

Series Unknown$2.6MDecember 2014
Rithmio
Rithmio
Acquired

Total Raised

$4.1M

Rounds

5

Seed$650kSeptember 2014
Vanquish Oncology
Vanquish Oncology

Total Raised

$6.4M

Rounds

3

Series Unknown$4.4MApril 2014
Phi Optics
Phi Optics

Total Raised

$2.2M

Rounds

5

Seed$250kNovember 2013